Cancer Drug Discovery: Advancing the Oncology Pipeline

SRI's approach to cancer research focuses on a tumor's interaction with a host organism, epigenetic changes in a tumor, and tumor biology: what contributes to its growth? A key focus is on the development of drugs that target hypoxia, lack of oxygen to a tumor. Cancer drug development involves several phases, including basic research, discovery, and testing. SRI researchers work on all preclinical stages and collaborate with a wide variety of government agencies and companies of all sizes to advance drugs from one stage to the next.